Skip to the page

Data / Form D filings / LUCIGEN CORP

LUCIGEN CORP: Form D filings

LUCIGEN CORP, a biotechnology company in Middleton, WI, filed 4 Form D notices with the SEC between 2012 and 2015. The latest, on March 17, 2015, reports $2.2 million sold of a $2.5 million offering to 29 investors.

Find out what LUCIGEN CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2905 PARMENTER STREET, Middleton, WI, 53562
Phone
(608) 831-9011
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Wisconsin
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1281599

The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 17, 2015Amendment$2,500,000$2,225,930$274,07029Dec 30, 2014sec.gov
Jan 14, 2015New notice$2,000,000$1,950,000$50,0001Dec 30, 2014sec.gov
Aug 22, 2012Amendment$1,699,919$1,699,919$00Mar 30, 2012sec.gov
Apr 2, 2012New notice$1,075,000$0$1,075,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Julie MeadDirector
Jeffrey WilliamsExecutive Officer, Director
Ralph KautenExecutive Officer, Director
David MeadExecutive Officer, Director
Timothy KonicekDirector
Christopher FortuneDirector

Every Form D from the week of Mar 16, 2015 · All recent filings in Wisconsin · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what LUCIGEN CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.